Global Pandemic Preparedness Fund: Mandatory Sovereign Contributions to Shared Infrastructure
Description
Establish a Global Pandemic Preparedness Fund (GPPF) capitalized by mandatory contributions from all countries, scaled by GDP and disease risk exposure. The fund operates a commons model: member countries co-own global surveillance networks, diagnostic hubs, and distributed vaccine manufacturing capacity.
Core structure: (1) Surveillance Commons: A unified real-time disease monitoring network with data nodes in every WHO region, connected to a central analytics platform that detects novel pathogens and emerging variants within days of emergence.
(2) Diagnostic Hub Network: Regional diagnostic capability centers (one per WHO region) equipped with capacity to develop, manufacture, and distribute diagnostic tests within 72 hours of pathogen identification.
(3) Distributed Manufacturing: 50 licensed mRNA and protein-based vaccine manufacturing facilities distributed across low-, middle-, and high-income countries, maintained in 'warm standby' status — producing essential vaccines during normal times, rapidly switching to pandemic vaccine production within 8 weeks of authorization.
(4) Pathogen Research and Development: A global R&D coordination mechanism (modeled on CEPI) that funds vaccine development for known pandemic-threat pathogens during inter-pandemic periods.
Implementation Pathway
Phase 1 (2026–2028)
- • GPPF charter negotiated and ratified by 100+ countries
- • Initial capitalization of $20B secured
- • Surveillance Commons architecture deployed in 3 WHO regions
- • First diagnostic hub operational
Phase 2 (2028–2031)
- • Surveillance Commons operational across all 6 WHO regions
- • 5 regional diagnostic hubs operational
- • 20 vaccine manufacturing facilities in warm standby
- • GPPF reaches sustainable $5B annual funding
Phase 3 (2031+)
- • 50 manufacturing facilities operational globally
- • Real-time surveillance active across 90% of world population
- • Pandemic response timelines reduced from 6+ months to 8-12 weeks
Required Resources
Impact Analysis
Overall Net Impact
Combined analysis across all timeframes
Short-term
0-2 years
No benefits identified
No harms identified
Mid-term
3-10 years
No benefits identified
No harms identified
Long-term
10+ years
No benefits identified
No harms identified